Skip to content
Biotech on the Web
  • Home
  • About Us
  • Account
  • Change Password
  • Forgot Password?
  • Login
  • Profile
  • Register
  • Reset Password
  • Users
  • Users List Item
  • About Us
  • Account
  • Change Password
  • Forgot Password?
  • Login
  • Profile
  • Register
  • Reset Password
  • Users
  • Users List Item

Trials for Alzheimer’s Drug Halted After Poor Results

Jan 8, 2018Biotech (General)
Share:

Pfizer Inc. on  Saturday said it would stop trying to discover new drugs for Alzheimer’s disease and Parkinson’s disease, abandoning costly but futile efforts to find effective treatments for the disorders.

 

More at: https://www.wsj.com/articles/pfizer-ends-hunt-for-drugs-to-treat-alzheimers-and-parkinsons-1515267654

Editorial Team
Author: Editorial Team

Categories

  • ALS
  • Alzheimer's
  • Autism
  • Biotech (General)
  • Biotech and the Internet
  • Biotech Stocks To Watch
  • Biotech Website Design
  • Cancer
  • Celiac Disease
  • Chronic Heart Failure
  • Clinical Trials
  • Computers
  • Contract Manufacturing
  • Coronavirus
  • Corporate News
  • COVID-19
  • Depression
  • Diabetes
  • Epilepsy
  • Heart Disease
  • Hepatitis B
  • Hypercholesterolemia
  • Multiple Sclerosis
  • Neurodegenerative Disorders
  • Other
  • Pharma
  • Policy
  • Protein Misfolding
  • Social Media
  • Stem Cells
  • Weight Loss

Advertisement




Developed by Think Up Themes Ltd. Powered by WordPress.